These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18625785)

  • 41. Cardiac resynchronization therapy for heart failure: has the time come?
    Yancy CW; Filardo G
    Circulation; 2009 Feb; 119(7):916-8. PubMed ID: 19237670
    [No Abstract]   [Full Text] [Related]  

  • 42. Rhythm management in pediatric heart failure.
    Berul CI; Dubin AM
    Congenit Heart Dis; 2006 Jul; 1(4):140-7. PubMed ID: 18377538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model.
    Lopshire JC; Zhou X; Dusa C; Ueyama T; Rosenberger J; Courtney N; Ujhelyi M; Mullen T; Das M; Zipes DP
    Circulation; 2009 Jul; 120(4):286-94. PubMed ID: 19597055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to Coceani: Has CRT earned a class I recommendation?
    Dimarco JP; Gold MR
    Circ Heart Fail; 2010 Jul; 3(4):559-60. PubMed ID: 20647492
    [No Abstract]   [Full Text] [Related]  

  • 46. Modified therapy for heart failure extends life. For some people with heart failure, a combination of two existing treatments lessens symptoms and delays death.
    Carlson MD
    Health News; 2004 Jul; 10(7):10. PubMed ID: 15239159
    [No Abstract]   [Full Text] [Related]  

  • 47. Modulation of cardiac contractility. A potential treatment of heart failure?
    Daubert JC
    Eur Heart J; 2008 Apr; 29(8):961-3. PubMed ID: 18367493
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. More is better with cardiac resynchronization therapy--but is it enough?
    Saxon LA
    Eur Heart J; 2006 Aug; 27(16):1891-2. PubMed ID: 16829539
    [No Abstract]   [Full Text] [Related]  

  • 50. Preventing heart failure and improving survival.
    Moss AJ
    N Engl J Med; 2010 Dec; 363(25):2456-7. PubMed ID: 21073362
    [No Abstract]   [Full Text] [Related]  

  • 51. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hybrid right-left cardiac resynchronization therapy defibrillator implantation in persistent left superior vena cava.
    Anselmino M; Marocco MC; Amellone C; Massa R
    Europace; 2009 Apr; 11(4):533-4. PubMed ID: 19112072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization techniques in cardiac resynchronization therapy.
    Fischer A
    Future Cardiol; 2009 Jul; 5(4):355-65. PubMed ID: 19656060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Management of advanced chronic heart failure].
    Oliva F; Macera F; Verde A; Frigerio M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ventricular bigeminy as a cause of CRT inefficacy and inappropriate cardioverter-defibrillator intervention].
    Oreziak A; Przybylski A; Walczak F
    Kardiol Pol; 2009 Jul; 67(7):807-11. PubMed ID: 19650008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-contact left ventricular endocardial mapping for cardiac resynchronisation therapy: a "slow conduction" towards the fast solution.
    Della Bella P; Carbucicchio C
    Heart; 2004 May; 90(5):483-4. PubMed ID: 15084532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Once upon a time, heart failure was easy.
    Leibovitch ER
    Geriatrics; 2005 Feb; 60(2):31-3. PubMed ID: 15742921
    [No Abstract]   [Full Text] [Related]  

  • 58. Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure?
    Exner DV
    J Am Coll Cardiol; 2009 Nov; 54(20):1847-9. PubMed ID: 19800192
    [No Abstract]   [Full Text] [Related]  

  • 59. Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans.
    Cleland JG; Coletta AP; Nikitin N; Louis A; Clark A
    Eur J Heart Fail; 2003 Jun; 5(3):391-8. PubMed ID: 12798839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial load reduction after cardiac resynchronization therapy: why does it change?
    Zócalo Y; Bia D; Reyes-Caorsi W; González-Moreno J; Armentano RL
    Eur J Echocardiogr; 2009 Jun; 10(4):461-2; author reply 462-3. PubMed ID: 19398475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.